Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04060121 · ClinicalTrials.gov registry record
Efficacy of Psychological Therapies in Patients With Functional Bowel Disorders
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 126
- Enrollment target
NCT04060121: Completed study, sponsored by Indiana University.
NCT04060121 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04060121 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
The purpose of this study is study bowel symptoms, quality of life, and personal factors that may affect your health. In Aim 1 of this study participants will be invited to complete 6 survey-based questionnaires online. In Aim 2 of this study will monitor the effectiveness of a 12 week therapy program on bowel symptoms and overall quality of life.
Primary Outcome
Presence of early adverse life events will be determine by self-reported questionnaire responses to the adverse childhood experiences (ACE) questionnaire (ACE score of one or higher, range 0-8)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2022-11-29 |
What the finished NCT04060121 record still lists
NCT04060121 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04060121 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04060121 about?
NCT04060121 is a clinical study titled "Efficacy of Psychological Therapies in Patients With Functional Bowel Disorders". The purpose of this study is study bowel symptoms, quality of life, and personal factors that may affect your health. In Aim 1 of this study participants will be invited to complete 6 survey-based questionnaires online. In Aim 2 of this study will monitor the effectiveness of a 12 week therapy prog...
What is the current status of trial NCT04060121?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2018-06-01. Estimated completion is 2022-11-29.
Who is sponsoring clinical trial NCT04060121?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI